Users Online: 1151
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment

Raut Lalit S

Year : 2015| Volume: 4| Issue : 1 | Page no: 38-40

   This article has been cited by
1 A multidisciplinary expert opinion on CINV and RINV, unmet needs and practical real-life approaches
Paolo Bossi,Mario Airoldi,Maria Antonietta Aloe Spiriti,Andrea Antonuzzo,Giorgio Bonciarelli,Alessia Campagna,Alessandra Cassano,Roberto Murialdo,Daniela Musio,Giovanni Silvano
Expert Opinion on Drug Safety. 2020; 19(2): 187
[Pubmed]  [Google Scholar] [DOI]
2 Topoisomerases as anticancer targets
Justine L. Delgado,Chao-Ming Hsieh,Nei-Li Chan,Hiroshi Hiasa
Biochemical Journal. 2018; 475(2): 373
[Pubmed]  [Google Scholar] [DOI]
3 Soft- and hard-lipid nanoparticles: a novel approach to lymphatic drug delivery
Seung-Hyun Jeong,Ji-Hun Jang,Hea-Young Cho,Yong-Bok Lee
Archives of Pharmacal Research. 2018;
[Pubmed]  [Google Scholar] [DOI]
4 Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models
Maofan Zhang,C. Tilden Hagan,Yuangzeng Min,Hayley Foley,Xi Tian,Feifei Yang,Yu Mi,Kin Man Au,Yusra Medik,Kyle Roche,Kyle Wagner,Zachary Rodgers,Andrew Z. Wang
Biomaterials. 2018;
[Pubmed]  [Google Scholar] [DOI]
5 Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy – An illustration with firsthand examples
Rui Xue Zhang,Jason Li,Tian Zhang,Mohammad A Amini,Chunsheng He,Brian Lu,Taksim Ahmed,HoYin Lip,Andrew M Rauth,Xiao Yu Wu
Acta Pharmacologica Sinica. 2018;
[Pubmed]  [Google Scholar] [DOI]
6 Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitor
Ada W.Y. Leung,Malathi Anantha,Wieslawa H. Dragowska,Mohamed Wehbe,Marcel B. Bally
Journal of Controlled Release. 2018; 286: 1
[Pubmed]  [Google Scholar] [DOI]
7 Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related Acute Myeloid Leukemia (AML) or AML With Myelodysplasia-Related Changes
Miryoung Kim,Sherry Williams
Annals of Pharmacotherapy. 2018; 52(8): 792
[Pubmed]  [Google Scholar] [DOI]
8 Co-delivery of paclitaxel and cisplatin with biocompatible PLGA–PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models
Jing Tian,Yuanzeng Min,Zachary Rodgers,Kin Man Au,C. Tilden Hagan,Maofan Zhang,Kyle Roche,Feifei Yang,Kyle Wagner,Andrew Z. Wang
J. Mater. Chem. B. 2017;
[Pubmed]  [Google Scholar] [DOI]
9 Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer
András Füredi,Kornélia Szebényi,Szilárd Tóth,Mihály Cserepes,Lilla Hámori,Veronika Nagy,Edina Karai,Péter Vajdovich,Tímea Imre,Pál Szabó,Dávid Szüts,József Tóvári,Gergely Szakács
Journal of Controlled Release. 2017; 261: 287
[Pubmed]  [Google Scholar] [DOI]
10 7-formyl-10-methylisoellipticine, a novel ellipticine derivative, induces mitochondrial reactive oxygen species (ROS) and shows anti-leukaemic activity in mice
Eileen G. Russell,Jianfeng Guo,Elaine C. O’Sullivan,Caitriona M. O’Driscoll,Florence O. McCarthy,Thomas G. Cotter
Investigational New Drugs. 2016; 34(1): 15
[Pubmed]  [Google Scholar] [DOI]
11 Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer
Jing Tian,Zachary Rodgers,Yuanzeng Min,Xiaomeng Wan,Hui Qiu,Yu Mi,Xi Tian,Kyle T. Wagner,Joseph M. Caster,Yanfei Qi,Kyle Roche,Tian Zhang,Jianjun Cheng,Andrew Z. Wang
Nanomedicine: Nanotechnology, Biology and Medicine. 2016;
[Pubmed]  [Google Scholar] [DOI]


Read this article